Gene therapy of severe combined immunodeficiencies

Journal of Gene Medicine

Volumn 3, Issue 3, 2001, Pages 201-206

  Cavazzana Calvo, Marina ^a   Hacein Bey, Salima ^a   Yates, Frank ^a   De Villartay, J P ^a   Le Deist, F ^a   Fischer, A ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Clinical trials; Gene therapy of hematopoietic disorders; Hematopoietic stem cells; Primary immunodeficiencies; Retrovirus; Severe combined immunodeficiencies (SCID)

Indexed keywords

UNIDENTIFIED RETROVIRUS;

ADENOSINE DEAMINASE;

COMBINED IMMUNODEFICIENCY; GENE THERAPY; GENETIC LINKAGE; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; METABOLISM; REVIEW; X CHROMOSOME;

ADENOSINE DEAMINASE; GENE THERAPY; HEMATOPOIETIC STEM CELLS; HUMANS; LINKAGE (GENETICS); SEVERE COMBINED IMMUNODEFICIENCY; X CHROMOSOME;

EID: 0035345136     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-2254(200105/06)3:3<201::AID-JGM195>3.0.CO;2-Z     Document Type: Review

References (50)

1. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000; 100: 157-168.
2. Piacibello W, Sanavio F, Severino A, et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34+ cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999; 93: 3736-3749.
3. Petzer AL, Zandstra PW, Piret JM, et al. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med 1996; 183: 2551-2558.
4. Ramsfjell V, Borge OJ, Cui L, et al. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c -kit and Flt-3 and inhibitory effects of TGF-beta and TNF-alpha. J Immunol 1997; 158: 5169-5177.
5. Fischer A, Cavazzana-Calvo M, de Saint Basile G, et al. Naturally occurring primary deficiency of the immune system. Annu Rev Immunol 1997; 15: 93-124.
6. Kung C, Pingel JT, Heikinheimo M, et al. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 2000; 6: 343-345.
7. Hershfield MS. Adenosine deaminase deficiency: clinical expression, molecular basis and therapy. Semin Hematol 1998; 35: 291-298.
8. Notarangelo LD, Stoppoloni G, Toraldo R, et al. Insulin-dependent diabetes mellirus and severe atopic dermatitis in a child with adenosine deaminase deficiency. Eur J Pediatr 1992; 151: 811-814.
9. Blaese RM, Culver KW, Miller AD, et al. T Lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270: 475-480.
10. Hoogerbrugge PM, Beusechem VW, Fischer A, et al. Bone marrow gene transfer in three patients with adenosine deaminase deficiency. Gene Ther 1996; 3: 179-183.
11. Bordignon C, Notarangelo LD, Nobili N, et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA immunodeficient patients. Science 1995; 270: 470-475.
12. Bordignon C, Bali P, Hershfield M, et al. Successful long-term PBL gene therapy for ADA deficient SCID in the absence of PEG-ADA. J Gene Med 2000; 2 (Suppl.): 5-26.
13. Kohn DB, Weinberg KI, Nolta JA, et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995; 1: 1017-1023.
14. Kohn DB, Hershfield MS, Carbonaro D, et al. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA deficient SCID neonates. Nat Med 1998; 4: 775-780.
15. de Saint Basile G, Arveiler B, Oberle I, et al. Close linkage of the locus for X chromosome linked severe combined immunodeficiency to polymorphic DNA markers in Xq 11-Xq 113. Proc Natl Acad Sci U S A 1987; 84: 7576-7579.
16. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor gamma c chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73: 147-157.
17. Parrish-Novak J, Dillon SR, Nelson A, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000; 408: 57-63.
18. Di Santo JP, Kühn R, Muller W. Common cytokine receptor gamma chain (gamma c)-dependent cytokines understanding in vivo functions by gene targeting. Immunol Rev 1995; 148: 19-34.
19. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Role of interleukin-2 (IL-2), IL-7 and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency - X1 bone marrow cells. Blood 1996; 88: 3901-3909.
20. Hacein-Bey S, Cavazzana-Calvo M, Le Deist F, et al. γc Gene transfer into SCID XI patients B-cell lines restores normal high-affinity IL2 receptor expression and function. Blood 1996; 87: 6108-6116.
21. Hacein-Bey S, de Saint Basile G, Lemerle J, Fischer A, Cavazzana-Calvo M. γc Gene transfer in the presence of stem cell factor, FLT-3L, interleukin-7 (IL-7), IL-1, and IL-15 cytokines restores T cell differentiation from gamma c (-) X-linked severe combined immunodeficient hematopoietic progenitor cells in murine fetal thymic organ cultures. Blood 1998; 92: 4090-4097.
22. Soudais C, Shiho T, Sharara LI, et al. Stable and functional lymphoid reconstitution common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer. Blood 2000; 95: 3071-3077.
23. Sugamura K, Asao H, Kondo M, et al. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in X SCID. Annu Rev Immunol 1996; 14: 179-205.
24. Candotti F, Johnston JA, Puck JM, et al. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency. Blood 1996; 87: 3097-3102.
25. Taylor N, Uribe L, Smith S, et al. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene. Blood 1996; 87: 3103-3107.
26. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669-672.
27. Otsu M, Sugamura K, Candotti F, et al. Stem cell gene therapy for X-Iinked severe combined immunodeficiency mice expressing a truncated common gamma chain. Paper presented at the Cold Spring Harbor Meeting on Gene Therapy, 25-29 September 2000.
28. Hacein-Bey S, Gross F, Nusbaum P, et al. Optimization of retroviral gene transfer protocol to maintain the lymphoid potential of progenitor cells. Hum Gene Ther 2001; 12: 291-301.
29. Zandstra PW, Lauffenburger DA, Eaves CJ. A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis. Blood 2000; 96: 1215-1222.
30. Hanenberg H, Xiao XL, Dilloo D, et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996; 2: 876-882.
31. Lo M, Bloom ML, Imada K, et al. Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach. Blood 1999; 94: 3027-3036.
32. Whitwam T, Haskins ME, Henthorn PS, et al. Retroviral marking of canine bone marrow: long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes. Blood 1998; 92: 1565-1575.
33. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X 1 disease. Blood 2000; 96 (Suppl. 11): 590.
34. Lantz O, Grandjean I, Matzinger P, et al. γ Chain required for naive CD4+ T cell survival but not for antigen proliferation. Nat Immunol 2000; 1: 54-58.
35. Patel DD, Gooding ME, Parrott RE, et al. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 2000; 342: 1325-1332.
36. Macchi P, Villa A, Gillani S, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995; 377: 65-68.
37. Puel A, Ziegler SF, Buckley RH, et al. Defective IL-7 R expression in T (-) B (+) NK (+) severe combined immunodeficiency. Nat Genet 1998; 20: 394-397.
38. Bunting KD, Sangster MY, Ihle JN, et al. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer. Nat Med 1998; 4: 58-64.
39. Schwarz K, Gauss GH, Ludwig L, et al. RAG mutations in human B cell-negative SCID. Science 1996; 274: 97-99.
40. Notarangelo LD, Villa A, Schwarz K. RAG and RAG defects. Curr Opin Immunol 1999; 11: 435-442.
41. Corneo B, Moshous D, Callebaut I, et al. Three-dimensional clustering of human RAG 2 gene mutations in severe combined immune deficiency. J Biol Chem 2000; 275: 12672-12675.
42. Taylor N, Bacon KB, Smith S, et al. Reconstitution of T cell receptor signaling in ZAP-70 deficient cells by retroviral transduction of the ZAP-70 gene. J Exp Med 1996; 184: 2031-2036.
43. Brown MP, Topham DJ, Sangster MY, et al. Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat Med 1998; 11: 1253-1260.
44. May C, Rivella S, Callegari J, et al. Therapeutic haemoglobin synthesis in β-thalassemic mice expressing lentivirus-encoded human β-globin. Nature 2000; 406: 82-84.
45. Kiem HP, Heyward S, Winkler A, et al. Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood 1997; 90: 4638-4645.
46. Rebel VI, Tanaka M, Lee JS, et al. One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-liter vesicular stomatitis virus G protein pseudotyped retrovirus. Blood 1999; 93: 2217-2224.
47. Kelly PF, Bonifacinot AC, Vandergriff JA. Multilineage transduction of non-human primate CD34+ hematopoietic cells using RD-1 14 pseudotyped oncoretroviruses. Mol Ther 2000; 1 (Suppl.): 125.
48. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
49. Zennou V, Petit C, Guetard D, et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000; 101: 173-185.
50. Miyoshi H, Smith KA, Mosier DE, et al. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999; 283: 682-686.